These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 28977571)

  • 1. Tacrolimus-induced hypertrophic cardiomyopathy in a patient with dermatomyositis.
    Noda K; Ukichi T; Furuya K; Yoshida K; Kingetsu I; Tanaka T; Kurosaka D
    Rheumatology (Oxford); 2017 Nov; 56(11):2037-2038. PubMed ID: 28977571
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tacrolimus and hypertrophic cardiomyopathy].
    Romero E; Hevia S; Castellanos D; Simarro C
    Med Clin (Barc); 1998 Jun; 110(20):804-5. PubMed ID: 9666425
    [No Abstract]   [Full Text] [Related]  

  • 3. Tacrolimus-related hypertrophic cardiomyopathy in an adult cardiac transplant patient.
    Liu T; Gao Y; Gao YL; Cheng YT; Wang S; Li ZZ; Zhang HB; Meng X; Ma CS; Dong JZ
    Chin Med J (Engl); 2012 Apr; 125(7):1352-4. PubMed ID: 22613615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive drugs and hypertrophic cardiomyopathy.
    Dhawan A; Mack DR; Langnas AN; Shaw BW; Vanderhoof JA
    Lancet; 1995 Jun; 345(8965):1644-5. PubMed ID: 7540242
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunosuppressive drugs and hypertrophic cardiomyopathy.
    Natazuka T; Ogawa R; Kizaki T; Ueno H; Shiotani H; Koizumi T; Nishimura R; Nakagawa T
    Lancet; 1995 Jun; 345(8965):1644. PubMed ID: 7540241
    [No Abstract]   [Full Text] [Related]  

  • 6. Anasarca and hypertrophic cardiomyopathy in a liver transplant patient on FK506: relieved after a switch to Neoral.
    Baruch Y; Weitzman E; Markiewicz W; Eisenman A; Eid A; Enat R
    Transplant Proc; 1996 Aug; 28(4):2250-1. PubMed ID: 8769215
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hypertrophic cardiomyopathy in preterm newborn with kidney transplanted mother].
    Méndez-Abad P; Zafra-Rodríguez P
    Arch Argent Pediatr; 2018 Dec; 116(6):e749-e752. PubMed ID: 30457729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tacrolimus: a cause of hypertrophic cardiomyopathy in pediatric heart transplant recipients?
    Scott JS; Boyle GJ; Daubeney PE; Miller SA; Law Y; Pigula F; Griffith BP; Webber SA
    Transplant Proc; 1999; 31(1-2):82-3. PubMed ID: 10083017
    [No Abstract]   [Full Text] [Related]  

  • 9. Reversal of tacrolimus-related hypertrophic cardiomyopathy after conversion to rapamycin in a pediatric liver transplant recipient.
    Turska-Kmieć A; Jankowska I; Pawłowska J; Kaliciński P; Kawalec W; Tomyn M; Markiewicz M; Teisseyre J; Czubkowski P; Rekawek J; Socha J
    Pediatr Transplant; 2007 May; 11(3):319-23. PubMed ID: 17430490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of tacrolimus-related hypertrophic obstructive cardiomyopathy 5 years after kidney transplant in a 6-year-old recipient.
    Jarzembowski TM; John E; Panaro F; Manzelli A; Cabrera A; Greco A; Varga P; Sankary H; Testa G; Benedetti E
    Pediatr Transplant; 2005 Feb; 9(1):117-21. PubMed ID: 15667624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus related hypertrophic cardiomyopathy in liver transplant recipients.
    Dehghani SM; Haghighat M; Imanieh MH; Zahmatkeshan M; Borzooei M; Amoozegar H; Zamirian M; Gholami S; Bahador A; Nikeghbalian S; Salahi H; Malek-Hosseini SA
    Arch Iran Med; 2010 Mar; 13(2):116-9. PubMed ID: 20187665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of tacrolimus-induced cardiomyopathy.
    Coley KC; Verrico MM; McNamara DM; Park SC; Cressman MD; Branch RA
    Ann Pharmacother; 2001 Sep; 35(9):985-9. PubMed ID: 11573873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive drugs and hypertrophic cardiomyopathy.
    Brand PL; Brus F
    Lancet; 1995 Jun; 345(8965):1644. PubMed ID: 7540240
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypertrophic cardiomyopathy associated with tacrolimus in paediatric transplant patients.
    Atkison P; Joubert G; Barron A; Grant D; Paradis K; Seidman E; Wall W; Rosenberg H; Howard J; Williams S
    Lancet; 1995 Apr; 345(8954):894-6. PubMed ID: 7535875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical tacrolimus treatment in a patient with dermatomyositis.
    Lampropoulos CE; D' Cruz DP
    Ann Rheum Dis; 2005 Sep; 64(9):1376-7. PubMed ID: 16100347
    [No Abstract]   [Full Text] [Related]  

  • 16. [Topical tacrolimus and resistant skin lesions of dermatomyositis].
    Peyrot I; Sparsa A; Loustaud-Ratti V; Liozon E; Vidal E; Bonnetblanc JM; Bedane C
    Rev Med Interne; 2006 Oct; 27(10):730-5. PubMed ID: 16987569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis.
    Yoshimasu T; Ohtani T; Sakamoto T; Oshima A; Furukawa F
    Eur J Dermatol; 2002; 12(1):50-2. PubMed ID: 11809595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of multi-target therapy in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with early-stage interstitial lung disease.
    Suda M; Kataoka Y; Tomishima Y; Jinta T; Rokutanda R; Kishimoto M; Okada M
    Scand J Rheumatol; 2017 Nov; 46(6):505-506. PubMed ID: 28649889
    [No Abstract]   [Full Text] [Related]  

  • 19. Topical tacrolimus in cutaneous lesions of dermatomyositis: lack of effect in side-by-side comparison in five patients.
    García-Doval I; Cruces M
    Dermatology; 2004; 209(3):247-8. PubMed ID: 15459546
    [No Abstract]   [Full Text] [Related]  

  • 20. Steroid-sparing effect of tacrolimus in a patient with juvenile dermatomyositis presenting poor bioavailability of cyclosporine A.
    Yamada A; Ohshima Y; Omata N; Yasutomi M; Mayumi M
    Eur J Pediatr; 2004 Sep; 163(9):561-2. PubMed ID: 15243811
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.